Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma
Clinical trial NCT06663046 · SUSPENDED
Trial details
- NCT number
- NCT06663046
- Sponsor
- Wondercel Biotech (ShenZhen)
- Status
- SUSPENDED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.